Diversified Trust CO Arrowhead Pharmaceuticals, Inc. Transaction History

Diversified Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 17, 2023	SELL	$26.2 - $36.08 $42,601 - $58,666	-1,626 Reduced 10.26%	14,224 $382,000
Q2 2023 Jul 18, 2023	BUY	$25.16 - $41.38 $251 - $413	10 Added 0.06%	15,850 $565,000
Q1 2023 Apr 07, 2023	BUY	$23.68 - $38.51 $12,218 - $19,871	516 Added 3.37%	15,840 $402,000
Q4 2022 Jan 17, 2023	BUY	$28.0 - $40.56 $200,396 - $290,287	7,157 Added 87.63%	15,324 $622,000
Q3 2022 Oct 14, 2022	BUY	$29.63 - $48.31 $241,988 - $394,547	8,167 New	8,167 $270,000

295

92.3M

1.33M

549K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.